ARRB1 Antibody

Datasheet
Code CSB-PA002134GA01HU
Size US$685
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No. P49407
Target Names ARRB1
Alternative Names ARB1 antibody; ARR1 antibody; ARRB1 antibody; ARRB1_HUMAN antibody; Arrestin 2 antibody; Arrestin beta 1 antibody; Arrestin beta-1 antibody; Beta-arrestin-1 antibody
Raised in Rabbit
Species Reactivity Human,Mouse,Rat
Immunogen Human ARRB1
Immunogen Species Homo sapiens (Human)
Isotype IgG
Purification Method Antigen Affinity purified
Concentration It differs from different batches. Please contact us to confirm it.
Buffer PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
Tested Applications ELISA,WB,IHC,IF
Protocols ELISA Protocol
Western Blotting(WB) Protocol
Immunohistochemistry (IHC) Protocol
Immunofluorescence (IF) Protocol
Troubleshooting and FAQs Antibody FAQs
Storage Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Target Data

Function Functions in regulating agonist-mediated G-protein coupled receptor (GPCR) signaling by mediating both receptor desensitization and resensitization processes. During homologous desensitization, beta-arrestins bind to the GPRK-phosphorylated receptor and sterically preclude its coupling to the cognate G-protein; the binding appears to require additional receptor determinants exposed only in the active receptor conformation. The beta-arrestins target many receptors for internalization by acting as endocytic adapters (CLASPs, clathrin-associated sorting proteins) and recruiting the GPRCs to the adapter protein 2 complex 2 (AP-2) in clathrin-coated pits (CCPs). However, the extent of beta-arrestin involvement appears to vary significantly depending on the receptor, agonist and cell type. Internalized arrestin-receptor complexes traffic to intracellular endosomes, where they remain uncoupled from G-proteins. Two different modes of arrestin-mediated internalization occur. Class A receptors, like ADRB2, OPRM1, ENDRA, D1AR and ADRA1B dissociate from beta-arrestin at or near the plasma membrane and undergo rapid recycling. Class B receptors, like AVPR2, AGTR1, NTSR1, TRHR and TACR1 internalize as a complex with arrestin and traffic with it to endosomal vesicles, presumably as desensitized receptors, for extended periods of time. Receptor resensitization then requires that receptor-bound arrestin is removed so that the receptor can be dephosphorylated and returned to the plasma membrane. Involved in internalization of P2RY4 and UTP-stimulated internalization of P2RY2. Involved in phosphorylation-dependent internalization of OPRD1 ands subsequent recycling. Involved in the degradation of cAMP by recruiting cAMP phosphodiesterases to ligand-activated receptors. Beta-arrestins function as multivalent adapter proteins that can switch the GPCR from a G-protein signaling mode that transmits short-lived signals from the plasma membrane via small molecule second messengers and ion channels to a beta-arrestin signaling mode that transmits a distinct set of signals that are initiated as the receptor internalizes and transits the intracellular compartment. Acts as signaling scaffold for MAPK pathways such as MAPK1/3 (ERK1/2). ERK1/2 activated by the beta-arrestin scaffold is largely excluded from the nucleus and confined to cytoplasmic locations such as endocytic vesicles, also called beta-arrestin signalosomes. Recruits c-Src/SRC to ADRB2 resulting in ERK activation. GPCRs for which the beta-arrestin-mediated signaling relies on both ARRB1 and ARRB2 (codependent regulation) include ADRB2, F2RL1 and PTH1R. For some GPCRs the beta-arrestin-mediated signaling relies on either ARRB1 or ARRB2 and is inhibited by the other respective beta-arrestin form (reciprocal regulation). Inhibits ERK1/2 signaling in AGTR1- and AVPR2-mediated activation (reciprocal regulation). Is required for SP-stimulated endocytosis of NK1R and recruits c-Src/SRC to internalized NK1R resulting in ERK1/2 activation, which is required for the antiapoptotic effects of SP. Is involved in proteinase-activated F2RL1-mediated ERK activity. Acts as signaling scaffold for the AKT1 pathway. Is involved in alpha-thrombin-stimulated AKT1 signaling. Is involved in IGF1-stimulated AKT1 signaling leading to increased protection from apoptosis. Involved in activation of the p38 MAPK signaling pathway and in actin bundle formation. Involved in F2RL1-mediated cytoskeletal rearrangement and chemotaxis. Involved in AGTR1-mediated stress fiber formation by acting together with GNAQ to activate RHOA. Appears to function as signaling scaffold involved in regulation of MIP-1-beta-stimulated CCR5-dependent chemotaxis. Involved in attenuation of NF-kappa-B-dependent transcription in response to GPCR or cytokine stimulation by interacting with and stabilizing CHUK. May serve as nuclear messenger for GPCRs. Involved in OPRD1-stimulated transcriptional regulation by translocating to CDKN1B and FOS promoter regions and recruiting EP300 resulting in acetylation of histone H4. Involved in regulation of LEF1 transcriptional activity via interaction with DVL1 and/or DVL2 Also involved in regulation of receptors other than GPCRs. Involved in Toll-like receptor and IL-1 receptor signaling through the interaction with TRAF6 which prevents TRAF6 autoubiquitination and oligomerization required for activation of NF-kappa-B and JUN. Binds phosphoinositides. Binds inositolhexakisphosphate (InsP6) (By similarity). Involved in IL8-mediated granule release in neutrophils. Required for atypical chemokine receptor ACKR2-induced RAC1-LIMK1-PAK1-dependent phosphorylation of cofilin (CFL1) and for the up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation. Involved in the internalization of the atypical chemokine receptor ACKR3. Negatively regulates the NOTCH signaling pathway by mediating the ubiquitination and degradation of NOTCH1 by ITCH. Participates to the recruitment of the ubiquitin-protein ligase to the receptor
Gene References into Functions
  1. The antitumor effect of miR296 in CRC are at least in part due to the inactivation of the RAC-alpha serine/threonine-protein kinase (AKT) signaling pathway induced by the suppression of ARRB1 expression. PMID: 30365090
  2. Beta-arrestin interacting with unphosphorylated ADRB2 fails to activate mitogen-activated protein kinase (MAPK) signaling and prolonged interaction of beta-arrestin with ADRB2 promoted the sorting of ADRB2 to lysosomes. PMID: 29330504
  3. Beta-arrestin-1 expression is associated with a poor prognosis in serous ovarian cancer patients.Beta-arrestin-1 role in the invadopodian function. PMID: 29439204
  4. Conformation of ADRB2 induced by the phosphorylation resulted in beta-arrestin binding. PMID: 29335412
  5. Bulky Phe substitution of Cys-147 in human arrestin-1 likely causes rod degeneration due to reduced stability of the protein, which induces unfolded protein response in expressing cells PMID: 29305604
  6. Results indicate a mechanism for beta-arrestin1 in the regulation of the prostate cancer procession through inhibiting FOXO3a. PMID: 29676828
  7. Studies indicate that the interaction of activated and phosphorylated GPCRs with the multifunctional adaptor proteins beta-arrestins (betaarrs) is crucial for regulation of their signaling and functional outcomes [Review]. PMID: 28651823
  8. The results show that PTEN controls multicellular assembly through a membrane-associated regulatory protein complex composed of beta-Arrestin1, ARHGAP21 and Cdc42. PMID: 28749339
  9. These results provide clear evidence that CXCR4- or CCR5-beta-arrestin complexes induce receptor endocytosis and signaling in the absence of G protein coupling and ligand-induced conformational changes of the receptor. PMID: 28733085
  10. Our results identify a new molecular mechanism involving miR-326 and Arrb1 as regulators of Sonic hedgehog medulloblastoma Cancer stem cells . Specifically, low levels of Arrb1 and miR-326 trigger and maintain Hh/Gli signaling and self-renewal PMID: 28716052
  11. This work demonstrates that the expression of FSHR and LHCGR can be induced in hGL5 cells but that the FSHR-dependent cAMP/PKA pathway is constitutively silenced, possibly to protect cells from FSHR-cAMP-PKA-induced apoptosis. PMID: 27502035
  12. Arrb1 reduced the chemotherapy-induced Lgr5 stem cell apoptosis by inhibiting endoplasmic reticulum stress-mediated mitochondrial apoptotic signaling. PMID: 27195676
  13. This study reveals contrasting abilities of IGF-1R to interact with each b-arrestin isoform, depending on the presence of the ligand and demonstrates the antagonism between the two b-arrestin isoforms in controlling IGF-1R expression and function, which could be developed into a practical anti-IGF-1R strategy for cancer therapy. PMID: 28581517
  14. Lowering the level of cellular FLNA caused an elevation in RalA activity and resulted in selective interference with the normal intracellular trafficking and signaling of D3R through beta-arrestins. PMID: 27188791
  15. findings suggest that knockdown of beta-arrestin 1 can suppress glioblastoma multiforme cell proliferation, invasion and glycolysis by inhibiting Src signaling PMID: 28442265
  16. the depleted beta-Arrestin1 reduced the interaction of P300 with Sp1, thus to reduce Sp1 binding to hTERT promoter, downregulate hTERT transcription, decrease telomerase activity, shorten telomere length, and promote Reh cell senescence. PMID: 28425985
  17. Data show that endothelin A receptor drives invadopodia function by direct interaction of beta-arrestin-1 (beta-arr1) with Rho guanine nucleotide exchange factor (GEF) 11 protein (PDZ-RhoGEF). PMID: 26522724
  18. The small GTPase Ras-related protein 2 (Rap2) was found to bind ArrB1 under resting conditions but dissociated upon formyl-Met-Leu-Phe stimulation. PMID: 27493245
  19. These results were consistent with those seen for beta2-AR. Thus, both beta-arrs negatively control AM1 receptor internalization, which depends on the C-tail of CLR. PMID: 28427767
  20. Results indicate a mechanism of beta-arrestin1 in modulating epithelial-mesenchymal transition (EMT) and glycogen synthase kinase 3 beta (GSK-3beta)/beta-catenin signaling in prostate cancer, and suggest that assessment of beta-arrestin1 may provide a potential therapeutic target for prostate cancer. PMID: 27620488
  21. The downregulation of beta-arrestins 1/2 in saphenous vein endothelial cells (SVECs) prevented the shear stress-induced rise in levels of phosphorylation of Akt and endothelial nitric oxide synthase (eNOS, Serine 1177). PMID: 28062183
  22. results suggest that ARRB1 plays an essential role in NK1R-mediated cell proliferation and G2/M transition in glioblastoma cells. Interference with ARRB1-mediated signaling via NK1R may have potential significance for therapeutic strategies targeting glioblastoma. PMID: 28341744
  23. The beta-arrestin1.STAM1 complex is necessary for promoting autophosphorylation of focal adhesion kinase (FAK). FAK is necessary for CXCL12-induced chemotaxis and associates with and localizes with beta-arrestin1 and STAM1 in a CXCL12-dependent manner. PMID: 27789711
  24. distinct ligands can leverage specific sequence elements on microR to regulate receptor endocytic lifetimes and the magnitude of arrestin-mediated signaling. PMID: 28153854
  25. CRIP1a can compete with beta-arrestins for interaction with C-terminal CB1R domains that could affect agonist-driven, beta-arrestin-mediated internalization of the CB1R. PMID: 27895162
  26. Low expression of ARRB1 is associated with lung cancer. PMID: 28035404
  27. In non-small cell lung cancer patients, the loss expression of beta-arrestin1 was frequently observed, and beta-arrestin1 expression was significantly correlated with the smoking index and E-cadherin expression, which all indicated beta-arrestin1's significant clinicopathologic role PMID: 26293896
  28. beta-arrestins regulate oxidative stress in a Nox4-dependent manner and increase fibrosis in heart failure. PMID: 26449263
  29. These results indicated that b-arr1 regulated ER stress/PUMA-induced mucosal epithelial apoptosis through suppression of the TNF-a/p65/iNOS signaling pathway activation and that b-arr1 is a potential therapeutic target for Portal hypertensive gastropathy. PMID: 26119788
  30. The nuclear accumulation of beta-arrestin 1 following TLR2 activation promote H4 acetylation at specific target gene promoters and may thus affect transcription of target genes in BM CD34+ cells. PMID: 26708616
  31. beta-arrestins functional involvement in myogenesis is presented. PMID: 26211463
  32. The identified receptor-phospho-selective mechanism for arrestin conformation and the spacing of the multiple phosphate-binding sites in the arrestin enable arrestin to recognize plethora phosphorylation states of numerous GPCRs. PMID: 26347956
  33. Data suggest that ARRB1 enhances hepatocellular carcinogenesis by inflammation-mediated Akt signaling. PMID: 26077142
  34. We conclude that beta-arrestin1 had a high expression in lung adenocarcinoma and beta-arrestin1 may be a promising biomarker to identify individuals with poor prognosis for patients with lung adenocarcinoma. PMID: 26097560
  35. Bradykinin stimulates pro-contractile signalling mechanisms in human myometrial cells and arrestin proteins play key roles in their regulation. PMID: 25766502
  36. After eight and 12 weeks of treatment with mirtazapine, scores on the 21-item Hamilton Depression Rating Scale (HAMD21) were significantly lower in patients with MDD with ARRB1 haplotype 1 than in those without haplotype 1 PMID: 25294870
  37. analysis of how NK1 receptor Gs versus Gq proteins and beta-arrestin signaling is determined by interactions in the water hydrogen bond network PMID: 26269596
  38. Multivariate analysis using the Cox regression model confirmed that co-expression of nuclear beta-arrestin1 and p65 was an independent prognostic factor for tumor progression (p = 0.008 PMID: 25820700
  39. Beta-arrestins regulate human cardiac fibroblast transformation in to a myofibroblast phenotype in ventricular remodeling. PMID: 25134464
  40. The potential role of ET-1/ETAR in promoting NF-kappaB signalling in EOC cells through beta-arr-1 recruitment, was examined. PMID: 24530737
  41. High ARBB1 expression is associated with metastasis in non-small cell lung cancers. PMID: 25401222
  42. A new role for Arr2 in the expression and activation of Androgen receptor and its potential relevance as a target for therapeutic intervention and monitoring of disease progression. PMID: 25109335
  43. Stimulation of multiple non-small cell lung cancer cell lines with nicotine led to enhanced recruitment of beta-arrestin-1 and E2F1 on vimentin PMID: 25600647
  44. IL6 stimulated SOD2 expression that, at least partially, contributed to the low level of ROS that would likely result in a sustained increase in the expression of IGF-1R through abolishment of beta-arrestin1 in docetaxel resistant cells. PMID: 24939178
  45. our findings reveal the existence of a novel mechanism by which ETAR/beta-arr1 signaling is integrated with the Wnt/beta-catenin pathway to sustain chemoresistance in epithelial ovarian cancer, and they offer a solid rationale for clinical evaluation PMID: 25377471
  46. TSH stimulated translocation of beta-arrestin-1 to TSHR. beta-arrestin-1 downregulation inhibited TSH-stimulated phosphorylation of ERK1/2, p38alpha, and AKT1. Activatory signals mediated by beta-arrestin-1 cause TSH-enhanced osteoblast differentiation in U2OS cells. PMID: 24723693
  47. the primary function of betaARRs and ECE-1 in SP-dependent inflammatory signaling is to promote resensitization, which allows the sustained NK1R signaling from the plasma membrane that drives inflammation PMID: 24898255
  48. A novel function of beta-arrestin1 binding to EZH2 to promote chronic myeloid leukemia progression by regulating BCR/ABL-histone H4 acetylation. PMID: 24937675
  49. Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer. PMID: 24837709
  50. The transient up-regulation of miR-525-3p, and the resultant repression of its direct targets ARRB1, TXN1 and HSPA9, is required for cell survival following irradiation. PMID: 24147004
  51. these results characterize CXCR4 structural domains and beta-arrestin1 as critical regulators of CXCR4 cell-surface expression in neuroblastoma. beta-Arrestin1 levels may therefore influence the CXCR4-driven metastasis of neuroblastoma as well as prognosis. PMID: 24452472
  52. Data show that beta-arrestins regulate Wnt3a-induced low density lipoprotein receptor-related protein 6 (Lrp6) phosphorylation by the regulation of the membrane dynamics of Amer1. PMID: 24265322
  53. Beta-arrestin-1 -mediated epigenetic mechanism controls beta-catenin activity.beta-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced beta-catenin signaling. PMID: 23208497
  54. engagement of the ACR D6 by its ligands activates a beta-arrestin1-dependent, G protein-independent signaling pathway that results in the phosphorylation of the actin-binding protein cofilin through the Rac1-PAK1-LIMK1 cascade. PMID: 23633677
  55. DCA, taurolithocholic acid, and oleanolic acid did not stimulate TGR5 association with beta-arrestin 1/2 or G protein-coupled receptor kinase (GRK) 2/5/6, as determined by bioluminescence resonance energy transfer PMID: 23818521
  56. betaArr1 and Mcl-1 are involved in the self-renewal and expansion of non-small cell lung carcinoma -cancer stem cells and are potential targets for anti-cancer therapy. PMID: 23418490
  57. Overexpression of beta 1 arrestin in glandular epithelia cells of mucinous adenocarcinoma is associated with gastric cardiac adenocarcinoma. PMID: 23317236
  58. These findings indicate a critical role for beta-arrestin1 in the pathogenesis of collagen-induced arthritis and T(H)17 cell differentiation. PMID: 23589893
  59. Data indicate that beta-arrestin1 is dispensable for STAT1 dephosphorylation and the termination of IFNgamma signaling. PMID: 23582260
  60. analysis of roles of beta-arrestin 1 and beta-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 PMID: 23449980
  61. roles for undetected ARRB1/2 in liver cancer progression PMID: 22961449
  62. Melanocortin 5 receptor signaling and internalization: role of MAPK/ERK pathway and beta-arrestins 1/2. PMID: 22871966
  63. Protein phosphatase 1beta (PP1beta) is identified as a phosphatase for the cluster of phosphorylated threonines ((353)TTETQRT(359)) within the sst(2A) somatostatin receptor carboxyl terminus that mediates beta-arrestin binding using siRNA knock-down screening. PMID: 21795688
  64. The influence of beta-arrestin adaptors and endocytosis mechanisms on plasma membrane diffusion and particle brightness of GFP-tagged neuropeptide Y (NPY) receptors, was investigated. PMID: 22487268
  65. Lys(157) within the putative nuclear localization sequence is critical to nuclear localization of beta-arrestin-1. PMID: 22267743
  66. Beta arrestin1 is differentially involved during receptor desensitization and endocytosis depending on the ligand. PMID: 22101011
  67. It was shown that beta-arrestin1 robustly interacts with nuclear HIF-1alpha and potentiates HIF-1alpha-dependent transcription of vascular endothelial growth factor-A. PMID: 21685944
  68. These findings identify a role for beta-arrestin and Dvl-2 scaffolds in APC-activated PAR1 cytoprotective signaling in human endothelial cells. PMID: 22106258
  69. Beta-Arrestin 1 modulates functions of autoimmune T cells from primary biliary cirrhosis patients. PMID: 21243522
  70. results highlight the emerging role of ARRB1 as an E3-ligase adaptor in the nucleus, and reveal how DNA damage may accumulate in response to chronic stress PMID: 21857681
  71. shows that both beta-arrestin-1 and beta-arrestin-2 play a novel and shared role in inhibiting G protein-dependent ERK1/2 phosphorylation. These findings reveal a new level of complexity for C3aR regulation by beta-arrestins in human mast cells PMID: 21589858
  72. beta-arrestins can thus differentially control distinct functional outputs of PTEN important for cell proliferation and migration. PMID: 21642958
  73. ARRB1 was significantly elevated in 155 newly diagnosed acute lymphoblastic leukemia patients, compared with 51 controls. PMID: 21479985
  74. Neurotensin triggers dopamine D2 receptor desensitization through a protein kinase C and beta-arrestin1-dependent mechanism. PMID: 21233215
  75. Nicotine-induced nuclear translocation of ARRB1, and its subsequent binding to E2F1 may be important in mediating the growth and progression of NSCLCs as a result of exposure to tobacco carcinogens. PMID: 21212384
  76. The A189 V FSHR stably expressed in HEK293N cells provoked ERK MAP kinases phosphorylation through beta-arrestins, independently of the canonical cAMP/PKA pathway. PMID: 20801186
  77. *ata demonstrate that PGE(2) partially stimulates hMSCs migration and proliferation by interaction of Pfn-1 and F-actin via EP2 receptor-dependent beta-arrestin-1/JNK signaling pathways. PMID: 20717968
  78. The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains. PMID: 20956518
  79. Nedd4-1 and beta-arrestin-1 as key regulators of NHE1 ubiquitylation, endocytosis, and function. PMID: 20855896
  80. beta-Arrestin 1 interacts with, and acts as an adaptor for AIP4, an E3 ubiquitin ligase responsible for TRPV4 ubiquitination. PMID: 20650893
  81. Increased expression of PGE2 in the lung tumor microenvironment may initiate a mitogenic signaling cascade composed of EP4, betaArrestin1, and c-Src which mediates cancer cell migration. PMID: 20353998
  82. Determinants in the receptor's core (Asn-289 and Lys-382) appear to regulate internalization of the receptor/beta-arrestin complex toward early endocytic endosomes during the initial step of endocytosis. PMID: 11726668
  83. findings suggest that beta-arrestin 1 acts as an effector for a novel function of PTHrP in cytoplasm PMID: 12220636
  84. role of beta-arrestin, dynamin, and clathrin-dependent pathway in internalization of the complement 5a anaphylatoxin receptor PMID: 12464600
  85. subcellular localization is determined by their intact N domain and the nuclear export signal at the C terminus PMID: 12538596
  86. examination of desensitization, internalization, and signaling functions demonstrated by RNA interference PMID: 12582207
  87. both beta-arrestin1 recruitment and the presence of Ser/Thr residues in the distal half of the C-terminal domain were necessary for maximal agonist-induced internalization PMID: 14709160
  88. results suggest that physiological levels of beta-arrestin1 may act as "dominant-negative" inhibitors of beta-arrestin2-mediated extracellular signal-regulated kinases 1 and 2 activation PMID: 14711824
  89. D6 is constitutively internalized via a ligand-independent, phosphorylation-independent association with beta-arrestin. PMID: 15084596
  90. protease-activated receptor-2-mediated migration of tumor cells requires both beta-arrestin-1 and -2 PMID: 15489220
  91. Mononuclear leukocytes of patients with depression showed significantly reduced immunoreactive quantities of beta-arrestin-1 PMID: 15514408
  92. beta-Arrestin 1 and Galphaq/11 have roles in activating RhoA and stress fiber formation following receptor stimulation PMID: 15611106
  93. beta-Arrestins bind and decrease cell-surface abundance of the Na+/H+ exchanger NHE5 isoform. PMID: 15699339
  94. beta-arrestin has a role in ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase PMID: 15878855
  95. Endogenous beta-arrestin1 functions exclusively in the phosphorylation-dependent receptor internalization, whereas endogenous beta-arrestin2, but not beta-arrestin1, is required for the phosphorylation-independent receptor internalization. PMID: 16181421
  96. results suggest that a GPCR conformation directed by the second intracellular loop, likely using the loop itself as a binding patch, may function as a switch for transitioning beta-arrestin from its inactive form to its active receptor-binding state. PMID: 16319069
  97. beta-arrestin 1 is a mediator of cellular migration and metastasis PMID: 16432186
  98. beta-arrestin and G proteins activate parathyroid hormone receptor-stimulated ERK1/2 pathways PMID: 16492667
  99. Our results show that PAR1-mediated activation of Src and ERK1/2 in HEK 293 cells was increased with overexpression of beta-arrestin1 or depletion of beta-arrestin2. PMID: 16580177
  100. ERK1/2 is activated by a chimeric neurokinin 1 receptor-beta-arrestin1 fusion protein PMID: 16670094

Show More

Hide All

Subcellular Location Cytoplasm, Nucleus, Cell membrane, Membrane, clathrin-coated pit, Cell projection, pseudopodium, Cytoplasmic vesicle
Protein Families Arrestin family
Database Links

HGNC: 711

OMIM: 107940

KEGG: hsa:408

STRING: 9606.ENSP00000409581

UniGene: Hs.503284

Most popular with customers

Newsletters

Get all the latest information on Events, Sales and Offers. Sign up for newsletter today.

Copyright © 2007-2018 www.cusabio.com CUSABIO TECHNOLOGY LLC All Rights Reserved. 鄂ICP备15011166号-1